Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.109ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.109ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.109EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.109EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.109ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.109ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.361EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.361EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.361ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.361ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.361EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.361EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.361ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.361ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.38ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.38ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.38EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.38EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
A.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.279EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.279EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.279ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.279ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.279EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.279EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.279ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.279ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AE.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AE.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AE.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AE.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
N.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
N.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used